Pharmacology of the maternal-placental-fetal-unit and fetal therapy

Progress in Pediatric Cardiology

Volumn 5, Issue 2, 1996, Pages 79-89

  Ward, Robert M ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Fetal arrhythmias; Fetal drug therapy; Maternal placental fetal unit (MPFU)

Indexed keywords

ANTIARRHYTHMIC AGENT; CEFALORIDINE; CEFALOTIN; DIGOXIN; GENTAMICIN;

CLINICAL PHARMACOLOGY; DRUG ABSORPTION; DRUG BLOOD LEVEL; FETOPLACENTAL UNIT; FETUS; FETUS DISEASE; GESTATIONAL AGE; HEART ARRHYTHMIA; HUMAN; PRENATAL CARE; PRIORITY JOURNAL; REVIEW;

EID: 0029924472     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/1058-9813(96)00153-1     Document Type: Article

References (70)

1. Ward RM, Green TP. Developmental pharmacology and toxicology: principles of study design and problems of methodology. Pharmacol Ther 1988;36:309-334.
2. Ward RM. Maternal drug therapy for fetal disorders. Semin Perinatol 1992;16:12-20.
3. Ward RM. Drug therapy of the fetus. J Clin Pharmacol 1993;33:780-789.
4. Ward RM. Pharmacological treatment of the fetus, clinical pharmacokinetic considerations. Clin Pharmacokinet 1995;28:343-350.
5. Ward RM. Pharmacological enhancement of fetal lung maturation. Clin Perinatol 1994;21:523-542.
6. Speiser PW, New MI. Prenatal diagnosis and management of congenital adrenal hyperplasia. Clin Perinatol 1994;21:631-645.
7. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-1669.
8. Connor EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:173-1180.
9. Maxwell DJ, Crawford DC, Curry PVM, Tynan MJ, Allan LD. Obstetric importance, diagnosis, and management of fetal tachycardias. Br Med J 1988;297:107-110.
10. Kleinman CS, Copel JA. Fetal cardiac arrhythmias: diagnosis and therapy. In: Creasy RK, Resnick R, editors. Maternalfetal medicine: principles and practice. Philadelphia: W.B. Saunders, 1994;326-341.
11. Kleinman CS, Donnerstein RL, DeVore GR et al. Fetal echocardiography for evaluation of in utero congestive heart failure. N Engl J Med 1982;306:568-575.
12. Ward RM. Maternal-placental-fetal unit: unique problems of pharmacologic study. Pediatr Clin North Am 1989;36:1075-1088.
13. Nau H. Physicochemical and structural properties regulating placenta drug transfer. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia: W.B. Saunders, 1992;130-141.
14. Scott LD. Gastrointestinal disease in pregnancy. In: Creasy RK, Resnick R, editors. Maternal-fetal medicine: principles and practice. Philadelphia: W.B. Saunders, 1994;1026-1039.
15. O'Sullivan GM, Sutton AJ, Thompson SA et al. Non-invasive measurement of gastric emptying in obstetric patients. Anesth Analg 1987;66:505-511.
16. Pritchard JA. Changes in the blood volume during pregnancy and delivery. Anesthesiology 1965;26:393-399.
17. Lund CJ, Donovan JC. Blood volume during pregnancy. Am J Obstet Gynecol 1967;98:393-401.
18. Pritchard JA, Adams RH. Erythrocyte production and destruction during pregnancy. Am J Obstet Gynecol 1960;79:750-757.
19. Pipe NGJ, Smith T, Halliday D, Edmonds CJ, Williams C, Coltart TM. Changes in fat, fat-free mass and body water in human normal pregnancy. Br J Obstet Gynaecol 1979;86:929-940.
20. Wasmoen TL. Placental proteins. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia: W.B. Saunders, 1992;87-95.
21. Martin C. Physiologic changes during pregnancy: the mother. In: Quilligan EJ, Kretchmer N, eds. Fetal and maternal medicine. New York: John Wiley & Sons, 1980;141-179.
22. Rosenfeld CR. Distribution of cardiac output in ovine pregnancy. Am J Physiol 1977;232:H231-H235.
23. Monga M, Creasy RK. Cardiovascular and renal adaptation to pregnancy. In: Creasy RK, Resnick R, editors. Maternalfetal medicine: principles and practice. Philadelphia: W.B. Saunders, 1994;758-767.
24. Davison JM, Dunlop W. Changes in renal hemodynamics and tubular function induced by normal human pregnancy. Semin Nephrol 1984;4:198-207.
25. Dunlop W. Serial changes in renal hemodynamics during normal human pregnancy. Br J Obstet Gynaecol 1981;881-889.
26. Kaufmann P, Scheffen I. Placental development. In: Polin RA, Fox WW, eds. Fetal and neonatal physiology. Philadelphia: W.B. Saunders, 1992;47-56.
27. Battaglia FC, Meschia G. An introduction to fetal physiology. San Diego: Academic Press, Inc., 1986;28-99.
28. Rosenfeld CR. Regulation of the placental circulation. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia: W.B. Saunders, 1992;56-62.
29. Hellman LM, Kobayashi M, Tolles WE, Cromb E. Ultrasonic studies on the volumetric growth of the human placenta. Am J Obstet Gynecol 1970;108:740-750.
30. Siler-Khodr TM. Endocrine and paracrine function of the human placenta. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia: W.B. Saunders, 1992;74-85.
31. Meigs RA, Ryan KJ. Cytochrome P-450 and steroid biosynthesis in the human placenta. Biochim Biophys Acta 1968;165:476-482.
32. Friis-Hansen B. Body composition during growth. Pediatrics 1971;47:264-274.
33. Nau H. Physicochemical and structural properties regulating placental drug transfer. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia: W.B. Saunders, 1992;130-141.
34. Pelkonen O, Kaltiala EH, Larmi TKI, Karki NT. Comparison of activities of drug-metabolizing enzymes in human fetal and adult livers. Clin Pharmacol Ther 1973;14:840-846.
35. Bland R. Formation of fetal lung liquid and its removal near birth. In: Polin RA, Fox WW, eds. Fetal and neonatal physiology. Philadelphia: W.B. Saunders, 1992;782-789.
36. Kurjak A, Kirkinen P, Latin V, Ivankovic D. Ultrasonic assessment of fetal kidney functions in normal and complicated pregnancies. Am J Obstet Gynecol 1981;141:266-270.
37. Ward RM. Starr TS, Snow BW, Bellinger MF, Pysher TJ, Zaino RJ. Serial renal function in an ovine model of unilateral fetal urinary tract obstruction. J Urol 1989;652-656.
38. Berman W, Ravenscroft PJ, Sheiner LB, Heymann MA, Melmon KL, Rudolph AM. Differential effects of digoxin at comparable concentrations in tissues of fetal and adult sheep. Circ Res 1977;41:635-642.
39. Soothill PW, Nicolaides KH, Rodeck CH, Gamsu H. Blood gases and acid-base status of the human second-trimester fetus. Obstet Gynecol 1986;68:173-176.
40. Dickinson JE, Eriksen NL, Meyer BA, Parisi VM. The effect of preterm birth on umbilical cord blood gases. Obstet Gynecol 1992;79:575-578.
41. Yancey MK, Moore J, Brady K, Milligan D, Strampel W. The effect of altitude on umbilical cord blood gases. Obstet Gynecol 1992;79:571-574.
42. Green TP, O'Dea RF, Mirkin BL. Determinants of drug disposition and effect in the fetus. Ann Rev Pharmacol Toxicol 1979;19:285-322.
43. Morrow S, Palmisano P, Cassady G. The placental transfer of cephalothin. J Pediatr 1968;73:262-264.
44. Stewart KS, Shafi M, Andrews J. Distribution of parenteral ampicillin and cephalosporins in late pregnancy. J Obstet Gynaecol 1973;80:902-908.
45. 3H-digoxin in humans. Br J Obstet Gynaecol 1976;83:879-884.
46. Kauffman RE, Azarnoff DL, Morris JA. Placental transfer and fetal urinary excretion of gentamicin - comparison between an animal model and the human fetus. In: Morselli, PL, Garattini S, Sereni F, editors. Basic and therapeutic aspects of perinatal pharmacology. New York: Raven Press, 1975;75-82.
47. Daubenfeld O, Modde H, Hirsch HA. Transfer of gentamicin to the foetus and the amniotic fluid during a steady state in the mother. Arch Gynaecol 1974;217:233-240.
48. Kleinman CS, Copel JA, Weinstein EM, Santulli TV, Hobbins JC. In utero diagnosis and treatment of fetal supraventricular tachycardia. Semin Perinatol 1985;9:113-129.
49. Wladimiroff JW, Stewart PA. Fetal therapy: treatment of fetal cardiac arrhythmias. Br J Hosp Med 1985;34:134-140
50. Smith TW. Digitalis: mechanisms of action and clinical use. N Engl J Med 1988;318:358-365.
51. Rogers MC, Willerson JT, Goldblatt A, Smith TW. Serum digoxin concentrations in the human fetus, neonate and infant. N Engl J Med 1972;287:1010-1013.
52. Smith TW, Haber E. Digitalis (third of four parts). N Engl J Med 1973;289:1063-1072.
53. Lilja H, Karlsson K, Lindecrantz K, Sabel KG. Treatment of intrauterine supraventricular tachycardia with digoxin and verapamil. J Perinat Med 1984;12:151-154.
54. Spinnato JA, Shaver DC, Flinn GS, Sibai BM, Watson DL, Marin-Garcia J. Fetal supraventricular tachycardia: in utero therapy with digoxin and quinidine. Obstet Gynecol 1984;64:730-735.
55. Given BD, Phillippe M, Sanders SP, Dzau VJ. Procainamide cardioversion of fetal supraventricular tachyarrhythmia. Am J Cardiol 1984;53:1460-1461.
56. Younis JS, Granat M. Insufficient transplacental digoxin transfer in severe hydrops fetalis. Am J Obstet Gynecol 1987;157:1268-1269.
57. Gembruch U, Hansmann M, Redel DA et al. Intrauterine therapy of fetal tachyarrhythmias: intraperitoneal administration of antiarrhythmic drugs to the fetus in fetal tachyarrhythmias with severe hydrops fetalis. J Perinat Med 1988;16:39-44.
58. Weiner CP, Thompson MIB. Direct treatment of fetal supraventricular tachycardia after failed transplacental therapy. Am J Obstet Gynecol 1988;158:570-573.
59. Nagashima M, Asai T, Suzuki C, Matsushima M, Ogawa A. Intrauterine supraventricular tachyarrhythmias and transplacental digitalisation. Arch Dis Child 1986;61:996-1000.
60. Killeen AA, Bowers LD. Fetal supraventricular tachycardia treated with high-dose quinidine: Toxicity associated with marked elevation of the metabolite, 3(S)-3-hydroxyquinidine. Obstet Gynecol 1987;70:445-449.
61. Leonard RF, Braun TE, Levy AM. Initiation of uterine contractions by disopyramide during pregnancy. N Engl J Med 1978;299:84-85.
62. Rey E, Duperron L, Gauthier R, Lemay M, Grignon A, LeLorier J. Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: A case report. Am J Obstet Gynecol 1985;153:311-312.
63. Owen J, Colvin EV, Davis RO. Fetal death after successful conversion of fetal supraventricular tachycardia with digoxin and verapamil. Am J Obstet Gynecol 1988;158:1169-1170.
64. Laurent M, Betremieux P Biron Y, LeHelloco A. Neonatal hypothyroidism after treatment by amiodarone during pregnancy. Am J Cardiol 1987;60:942.
65. Tunstall ME. The effect of propranolol on the onset of breathing at birth. Br J Anaesthesia 1969;41:792.
66. Pruyn SC, Phelan JP, Buchanan GC. Long-term propranolol therapy in pregnancy: Maternal and fetal outcome. Am J Obstet Gynecol 1979;135:485-489.
67. Habib A, McCarthy JS. Effects on the neonate of propranolol administered during pregnancy. J Pediatr 1977;91:808-811.
68. Rubin PC. Beta-blockers in pregnancy. N Engl J Med 1981;305:1323-1326
69. Mason JW. Amiodarone. N Engl J Med 1987;316:455-466.
70. Vrobel TR, Miller PE, Mostow ND, Rakita L. A general overview of amiodarone toxicity: its prevention, detection, and management. Progr Cardiovasc Dis 1989;31:393-426.